PROF. DR. KIEW LIK VOON
Department of Pharmacology
Faculty of Medicine
lvkiewum.edu.myView CV | |
Publons | |
Scopus Link | |
Biography | |
Lik-Voon Kiew obtained his Ph.D. degree in Biopolymer Technology and Therapeutics from the Universiti Malaya, Malaysia. His research interests and expertise are in the development of nano-sized complexes and particles for (i) anticancer and organ-selective drug delivery and therapy, (ii) bio-sensing / medical diagnosis purposes. He also evaluates synthetic and bioactive compounds/materials for toxicity, physiology impact and disease treatment efficacy. He also assesses the acute and chronic impacts of intravenous administration of nano-drug-carriers and nanotherapeutics to the cardiovascular physiology of rats using radio-telemetry techniques. He has 22 years of research experience in nanomedicine and pharmacology, and has published over 65 research manuscripts and graduated 10 PhD students and 6 MSc students. He has also been appointed previously as the visiting Associate Professor to the National Chiao Tung University, Taiwan (2020) and visiting scientist to the Principe Felipe Research Centre, Valencia, Spain (2014). Kiew is currently a Professor and the Head of the Department of Pharmacology, Faculty of Medicine, Universiti Malaya (UM), Malaysia. He is also a Jointly-Appointed Professor of the College of Biological Science & Technology, National Yang Ming Chiao Tung University (NYCU), Taiwan. He has 15 years of experience as a pharmacologist and pharmacology educator, and has been appointed previously as the external examiner (Pharmacology) for the (i) Second Professional Bachelor of Dental Surgery Examination 2021/2022, International Medical University, Malaysia, (ii) Second Professional Examination 2020/2021, Bachelor of Dentistry, National University of Malaysia (UKM), (iii) Second Professional Examination 2019/2020, Bachelor of Dental Surgery, Penang International Dental College-MASHA University, Malaysia, (iv) Pre-Clinical Professional Examination, Bachelor of Medicine/Bachelor of Surgery (MBBS) program, Quest International University Perak, Malaysia (2019); the internal examiner for the Bachelor of Dental Surgery program and the Bachelor of Medicine/Bachelor of Surgery (MBBS/UMMP) program, University of Malaya, Malaysia; a PhD thesis examiner for the National University of Singapore (2021) and the University of Nottingham Malaysia (2019), and an independent assessor for the Academic Promotion Exercise of Monash University Malaysia (2021-2022). He is also the Deputy head (Asia Pacific Region), Internationalization Unit, Faculty of Medicine; and the Protem Head, Centre of Excellence for Innovative Medical Devices, Universiti Malaya, Malaysia. In the research community, Kiew serves as an International Committee of the Controlled Release Society (CRS, 2019 - 2022), a committee member for the (i) International Organization for Standardization (ISO) Technical Committee 229 / Work Group 3 (ISO/TC 229/WG 03) "Health, Safety and Environmental Aspects of Nanotechnologies", and (ii) Technical Committee TC15 - Nanotechnologies (Work Group 3 - Safety and Health), Department of Standards Malaysia, Ministry of International Trade and Industry Malaysia (2019 – present), a member of The Ministry of Education Malaysia Research Fund Evaluation Committee (2019-2020), a committee member of the Malaysian Local Chapter of the Controlled Release Society (MyCRS), and a scholarship panellist for the Human Life Advancement Foundation (2016-2017, 2019-2020). He s also an editor for the Journal of Health and Translational Medicine (2017- present), a guest editor for the Journal of Drug Delivery and Translational Research (2018), and a manuscript reviewer for Theranostics, Nanomedicine NBM, the Journal of Biomedical Nanotechnology, RSC Advances, International Journal of Nanomedicine, International Journal of Pharmaceutics, Biomedicine & Pharmacotherapy, Journal of Photochemistry & Photobiology A: Chemistry, Journal of Materials Chemistry B and BMC Nephrology. |
Publication
Finance
Project Title | Progress | Status |
---|---|---|
Fundamental Investigation On The Nanocarrier-Assisted Rapid Drug Urothelial Mucopenetration And Ultrasound-Regulated Tumour-Selective Bladder Drug Delivery To Improve Intravesical Bladder Cancer Therapy |
|
on going |
The Development of ultrasound-responsive multistage-ultrasmall nanoparticles for improved tumour penetration and renal clearance |
|
end |
This information is generated from Research Grant Management System |
Immune-stealth VP28-conjugated heparin nanoparticles for enhanced and reversible anticoagulation
PDADMAC/Alginate-Coated Gold Nanorod For Eradication of Staphylococcus Aureus Biofilms
Ruthenium(II) polypyridyl complexes as emerging photosensitisers for antibacterial photodynamic therapy
Bispecific antibodies for targeted delivery of anti-cancer therapeutic agents: A review